Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS).

Clinical trial NCT07042516 · RECRUITING

Trial details

NCT number: NCT07042516
Sponsor: Tioga Pharmaceuticals
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Vasomotor Symptoms

Start date: 2025-08-13
Primary completion: 2026-12-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.